Herti 440 mg Injection – Trastuzumab 440 mg

Product Overview

Herti 440 mg Injection is an anti-cancer medicine containing Trastuzumab 440 mg, a targeted monoclonal antibody used in the treatment of certain HER2-positive cancers. It is prescribed by oncology specialists for eligible patients with specific types of breast cancer and stomach (gastric or gastroesophageal junction) cancer.

Herti 440 mg works by targeting the HER2 protein, which may be present in unusually high amounts on certain cancer cells. By binding to this protein, Trastuzumab helps slow cancer-cell growth and supports the body’s immune response against these cells.

The medicine should only be used after appropriate HER2 testing and under the supervision of a qualified oncologist.

Composition and Product Details

• Brand Name: Herti
• Salt Name: Trastuzumab
• Strength: 440 mg
• Dosage Form: Powder for Concentrate for Solution for Infusion
• Route of Administration: Intravenous infusion
• Manufacturer/Marketer: Hetero Healthcare Limited
• Packaging: Vial; confirm the supplied diluent and pack contents from the actual product carton.

Uses of Herti 440 mg Injection

Herti 440 mg may be prescribed as part of a combination treatment plan for certain HER2-positive cancers, depending on the patient’s diagnosis and the locally approved product information.

1. HER2-Positive Breast Cancer

Trastuzumab is used in selected patients with HER2-positive early-stage or metastatic breast cancer. It may be prescribed alongside chemotherapy or other targeted medicines, depending on the treatment stage and clinical plan.

2. HER2-Positive Gastric Cancer

Trastuzumab may also be used for eligible patients with HER2-positive metastatic stomach or gastroesophageal junction cancer, generally in combination with other prescribed anti-cancer medicines.

Important: HER2 status must be confirmed through appropriate laboratory testing. Not every breast or stomach cancer is suitable for Trastuzumab treatment.

How Does Herti 440 mg Work?

Herti 440 mg contains Trastuzumab, a humanised monoclonal antibody that specifically binds to the HER2 receptor on certain cancer cells.

HER2 is a protein involved in cell growth and division. When cancer cells produce excessive amounts of HER2, they may grow and multiply more rapidly.

Trastuzumab attaches to the HER2 receptor and interferes with its growth-promoting activity. It can also help the immune system recognise and attack HER2-positive cancer cells.

The treatment response varies between patients and is monitored by the oncology team.

How Is Herti 440 mg

Injection Administered?

Herti 440 mg is administered through an intravenous infusion by a qualified healthcare professional in an appropriate medical setting.

The prescribed dose and treatment schedule depend on factors such as the cancer type, treatment plan, body weight, previous therapy and individual response.

Trastuzumab regimens may use weekly or three-weekly schedules. The 440 mg vial strength does not automatically represent the dose required for every patient.

The medicine requires appropriate reconstitution and preparation before administration. Patients should never attempt to prepare or inject this medicine themselves.

Possible Side Effects

Like other prescription oncology medicines, Herti 440 mg may cause side effects. These can vary depending on the patient and combination treatment.

Commonly reported effects may include:

• Fever and chills
• Nausea or vomiting
• Diarrhoea
• Headache
• Fatigue or weakness
• Infusion-related reactions
• Skin rash
• Muscle or joint pain
• Changes in blood-cell counts, particularly when used with chemotherapy

Serious Side Effects

Trastuzumab can cause serious heart-related problems, including reduced heart function and heart failure. It may also cause severe infusion reactions, allergic reactions and lung-related complications.

Seek immediate medical attention if symptoms such as breathing difficulty, chest discomfort, severe dizziness, facial swelling or sudden worsening of health occur.

Important Precautions and Warnings

Heart Function Monitoring

Patients may require heart-function assessments before and during treatment. Inform the oncologist about any existing heart condition or previous heart-related treatment.

Pregnancy and Breastfeeding

Trastuzumab may cause harm to an unborn baby. Patients who are pregnant, planning pregnancy or breastfeeding should discuss the risks with their oncologist before treatment. Effective contraception and the recommended precautions after treatment should follow the approved prescribing information.

Allergic Reactions

Inform the healthcare team about previous allergic reactions to Trastuzumab or any of the product’s ingredients.

Existing Medical Conditions

Tell the oncologist about existing lung, heart or other medical conditions and all medicines currently being used.

Drug Interactions

Before starting Herti 440 mg, disclose all prescription medicines, over-the-counter products, supplements and previous cancer treatments to the treating oncologist.

Certain chemotherapy medicines, particularly anthracyclines, may increase the risk of heart-related complications when used in treatment plans involving Trastuzumab. The oncology team will assess the combination and arrange appropriate monitoring.

Do not start, stop or change any medicine without medical advice.

Storage and Handling

• Store the product according to the manufacturer’s instructions, generally under refrigerated conditions at 2°C–8°C.
• Do not freeze the medicine.
• Protect the product from inappropriate storage conditions.
• Follow the product-specific instructions for reconstitution and handling.
• Reconstituted and diluted solutions must be stored and used within the time limits specified in the approved product information.
• Preparation and disposal must be handled by trained healthcare professionals.

Always check the actual carton and package insert for product-specific storage instructions.

Why Choose Speciality Drugs?

Speciality Drugs is a pharmaceutical distributor and exporter supporting pharmaceutical sourcing requirements across healthcare markets.

For Herti 440 mg enquiries, customers can contact Speciality Drugs for product availability, quotation requests and supply-related information.

• Pharmaceutical distribution and export support
• Product sourcing assistance
• Enquiry and quotation support
• Assistance for pharmacies, distributors and healthcare businesses

Contact Speciality Drugs for current availability and a product quotation.

Frequently Asked Questions (FAQs)

1. What is Herti 440 mg Injection?

Herti 440 mg is a prescription injection containing Trastuzumab 440 mg, used for certain HER2-positive cancers.

2. What is the active ingredient in Herti 440 mg Injection ?

The active ingredient is Trastuzumab, a monoclonal antibody that targets the HER2 protein.

3. Who manufactures Herti 440 mg Injection?

Herti 440 mg is marketed by Hetero Healthcare Limited. Confirm the manufacturer and marketer details on the current product packaging.

4. What is Herti 440 mg Injection used for?

It may be prescribed for eligible patients with certain HER2-positive breast cancers and gastric or gastroesophageal junction cancers.

5. Is HER2 testing required before treatment?

Yes. Appropriate HER2 testing is required to determine whether a patient’s cancer is suitable for Trastuzumab treatment.

6. How is Herti 440 mg administered?

It is administered through an intravenous infusion by a qualified healthcare professional.

7. Is Herti 440 mg Injection a chemotherapy medicine?

Trastuzumab is a targeted monoclonal antibody therapy. It is different from conventional chemotherapy, although both may be used together in some treatment plans.

8. What are the common side effects?

Possible side effects include fever, chills, nausea, diarrhoea, fatigue, headache and infusion-related reactions.

9. Can Herti 440 mg Injection affect the heart?

Yes. Trastuzumab may reduce heart function or cause heart failure in some patients. Medical monitoring is important.

10. Can it be used during pregnancy?

Trastuzumab may harm an unborn baby. Pregnancy must be discussed with the treating oncologist before treatment.

11. Does Herti 440 mg require refrigeration?

It is generally stored at 2°C–8°C. Always follow the storage instructions printed on the actual product packaging.

12. Can patients administer Herti 440 mg at home?

No. It requires professional preparation and intravenous administration in an appropriate medical setting.

13. Can Herti 440 mg be used with other cancer medicines?

It may be combined with selected cancer medicines when prescribed by an oncologist. The treatment combination depends on the cancer type and patient-specific factors.

14. Is the 440 mg vial the correct dose for every patient?

No. The prescribed dose is determined by the oncologist according to the treatment regimen and patient-specific factors.

15. How can I enquire about Herti 440 mg Injection?

Contact Speciality Drugs for product availability, pricing and quotation-related enquiries.

Medical Disclaimer: This content is for general product information and educational purposes only. Herti 440 mg is a prescription oncology medicine. Its use, dosage, preparation and monitoring must be determined by a qualified oncologist. This information does not replace professional medical advice.